List of Tables
Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oncolytic Virotherapy
Table 3. Key Players of Gene Transfer
Table 4. Key Players of Gene-Induced Immunotherapy
Table 5. Global Cancer Gene Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cancer Gene Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cancer Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cancer Gene Therapy Market Share by Region (2017-2022)
Table 9. Global Cancer Gene Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cancer Gene Therapy Market Share by Region (2023-2028)
Table 11. Cancer Gene Therapy Market Trends
Table 12. Cancer Gene Therapy Market Drivers
Table 13. Cancer Gene Therapy Market Challenges
Table 14. Cancer Gene Therapy Market Restraints
Table 15. Global Cancer Gene Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cancer Gene Therapy Market Share by Players (2017-2022)
Table 17. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2021)
Table 18. Ranking of Global Top Cancer Gene Therapy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Gene Therapy Product Solution and Service
Table 22. Date of Enter into Cancer Gene Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Gene Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2017-2022)
Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2023-2028)
Table 28. Global Cancer Gene Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cancer Gene Therapy Revenue Market Share by Application (2017-2022)
Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cancer Gene Therapy Revenue Market Share by Application (2023-2028)
Table 32. North America Cancer Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Cancer Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Cancer Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Cancer Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Cancer Gene Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Cancer Gene Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Cancer Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Cancer Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Cancer Gene Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Cancer Gene Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 42. Adaptimmune Company Detail
Table 43. Adaptimmune Business Overview
Table 44. Adaptimmune Cancer Gene Therapy Product
Table 45. Adaptimmune Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 46. Adaptimmune Recent Development
Table 47. Bluebird bio Company Detail
Table 48. Bluebird bio Business Overview
Table 49. Bluebird bio Cancer Gene Therapy Product
Table 50. Bluebird bio Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 51. Bluebird bio Recent Development
Table 52. Celgene Company Detail
Table 53. Celgene Business Overview
Table 54. Celgene Cancer Gene Therapy Product
Table 55. Celgene Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 56. Celgene Recent Development
Table 57. Shanghai Sunway Biotech Company Detail
Table 58. Shanghai Sunway Biotech Business Overview
Table 59. Shanghai Sunway Biotech Cancer Gene Therapy Product
Table 60. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 61. Shanghai Sunway Biotech Recent Development
Table 62. Shenzhen SiBiono GeneTech Company Detail
Table 63. Shenzhen SiBiono GeneTech Business Overview
Table 64. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
Table 65. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 66. Shenzhen SiBiono GeneTech Recent Development
Table 67. SynerGene Therapeutics Company Detail
Table 68. SynerGene Therapeutics Business Overview
Table 69. SynerGene Therapeutics Cancer Gene Therapy Product
Table 70. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 71. SynerGene Therapeutics Recent Development
Table 72. Altor BioScience Company Detail
Table 73. Altor BioScience Business Overview
Table 74. Altor BioScience Cancer Gene Therapy Product
Table 75. Altor BioScience Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 76. Altor BioScience Recent Development
Table 77. Amgen Company Detail
Table 78. Amgen Business Overview
Table 79. Amgen Cancer Gene Therapy Product
Table 80. Amgen Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 81. Amgen Recent Development
Table 82. Argenx Company Detail
Table 83. Argenx Business Overview
Table 84. Argenx Cancer Gene Therapy Product
Table 85. Argenx Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 86. Argenx Recent Development
Table 87. BioCancell Company Detail
Table 88. BioCancell Business Overview
Table 89. BioCancell Cancer Gene Therapy Product
Table 90. BioCancell Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 91. BioCancell Recent Development
Table 92. GlaxoSmithKline Company Detail
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Cancer Gene TherapyProduct
Table 95. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 96. GlaxoSmithKline Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Cancer Gene TherapyProduct
Table 100. Merck Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 101. Merck Recent Development
Table 102. OncoGenex Pharmaceuticals Company Detail
Table 103. OncoGenex Pharmaceuticals Business Overview
Table 104. OncoGenex Pharmaceuticals Cancer Gene TherapyProduct
Table 105. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 106. OncoGenex Pharmaceuticals Recent Development
Table 107. Transgene Company Detail
Table 108. Transgene Business Overview
Table 109. Transgene Cancer Gene TherapyProduct
Table 110. Transgene Revenue in Cancer Gene Therapy Business (2017-2022) & (US$ Million)
Table 111. Transgene Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Gene Therapy Market Share by Type: 2021 VS 2028
Figure 2. Oncolytic Virotherapy Features
Figure 3. Gene Transfer Features
Figure 4. Gene-Induced Immunotherapy Features
Figure 5. Global Cancer Gene Therapy Market Share by Application in 2021 & 2028
Figure 6. Hospitals Case Studies
Figure 7. Diagnostics Centers Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Cancer Gene Therapy Report Years Considered
Figure 10. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Cancer Gene Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Cancer Gene Therapy Market Share by Region: 2021 VS 2028
Figure 13. Global Cancer Gene Therapy Market Share by Players in 2021
Figure 14. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2021
Figure 16. North America Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Cancer Gene Therapy Market Share by Country (2017-2028)
Figure 18. United States Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Cancer Gene Therapy Market Share by Country (2017-2028)
Figure 22. Germany Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Cancer Gene Therapy Market Share by Region (2017-2028)
Figure 30. China Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Cancer Gene Therapy Market Share by Country (2017-2028)
Figure 38. Mexico Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Cancer Gene Therapy Market Share by Country (2017-2028)
Figure 42. Turkey Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 45. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 46. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 47. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 48. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 49. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 50. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 51. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 52. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 53. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 55. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 56. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 57. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed